Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalcetrapib Phase II in CHD or CHD Risk Equivalent
NCT00353522Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dalcetrapib in coronary heart disease (CHD), sponsored by Roche. Started Jul 2006; status: completed.
02
Drugs
dalcetrapib
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00353522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353522.